Aktivitas Antikanker Senyawa Kompleks Mononuklir Ruthenium
Aktivitas Antikanker Senyawa Kompleks Mononuklir Ruthenium
Kristiyana/4311414040
Jurusan Kimia
Fakultas Matematika dan Ilmu Pengetahuan Alam
Universitas Negeri Semarang
Abstrak
PENDAHULUAN
Latar Belakang
Manfaat
ISI
PENUTUP
Simpulan
DAFTAR PUSTAKA
[6] S. H. van Rijt and P. J. Sadler, Current applications and future potential for
bioinorganic chemistry in the development of anticancer drugs,Drug
Discovery Today,vol.14,no.23-24,pp. 10891097, 2009.
[7] M. A. Jakupec, M. Galanski, V. B. Arion, C. G. Hartinger, and B. K. Keppler,
Antitumour metal compounds: more than theme and variations,Dalton
Transactions,no.2,pp.183194,2008.
[12] P. Zhang, J. Chen, and Y. Liang, DNA binding, cytotoxicity, and apoptotic-
inducing activity of ruthenium(II) polypyridyl complex,Acta Biochimica et
Biophysica Sinica,vol.42,no.7,pp. 440449, 2010.
[33] R. E. Aird, J. Cummings, A. A. Ritchie et al., In vitro and in vivo activity and
cross resistance profiles of novel ruthenium(II) organometallic arene
complexes in human ovarian cancer,British Journal of Cancer, vol. 86, no.
10, pp. 16521657, 2002.